These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144 [TBL] [Abstract][Full Text] [Related]
5. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. Schulman S; Rhedin AS; Lindmarker P; Carlsson A; Lärfars G; Nicol P; Loogna E; Svensson E; Ljungberg B; Walter H N Engl J Med; 1995 Jun; 332(25):1661-5. PubMed ID: 7760866 [TBL] [Abstract][Full Text] [Related]
7. Prevention and management of venous thrombosis and pulmonary embolism. Mandel SR; Johnson G N C Med J; 1973 Feb; 34(2):114-9. PubMed ID: 4568848 [No Abstract] [Full Text] [Related]
8. Duration of anticoagulant therapy in venous thrombo--embolism. O'Sullivan EF Med J Aust; 1972 Nov; 2(20):1104-7. PubMed ID: 4640564 [No Abstract] [Full Text] [Related]
9. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. ; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815 [TBL] [Abstract][Full Text] [Related]
10. [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism]. Hamerschlak N; Rosenfeld LG Arq Bras Cardiol; 1996 Sep; 67(3):209-13. PubMed ID: 9181717 [No Abstract] [Full Text] [Related]
20. Anticoagulant and antithrombotic therapy in deep venous thrombosis and pulmonary embolism. Stein PD Henry Ford Hosp Med J; 1988; 36(1):35-40. PubMed ID: 3294212 [No Abstract] [Full Text] [Related] [Next] [New Search]